Gliotoxin
(Synonyms: 胶霉毒素,Aspergillin) 目录号 : GC17255An immunosuppressive mycotoxin with diverse biological effects
Cas No.:67-99-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cell experiment [1]: | |
Cell lines |
breast cancer cell lines (MCF-7 and MDA-MB-231 cells) |
Preparation method |
The solubility of this compound in DMSO is >10mM. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Reacting condition |
1 nM to 10 μM |
Applications |
Gliotoxin inhibited proliferation of six breast cancer cell lines in culture and protein prenylation over the same range of concentrations. Treatment with gliotoxin for 24 h led to a clear dose-dependent inhibition of Lamin B farnesylation and Rap1A geranylgeranylation in breast cancer cell lines. Taken together these findings indicated that the observed antitumor activity of gliotoxin in breast cancer cell lines was most likely due to prenyltransferase inhibition. |
Animal experiment [2]: | |
Animal models |
Inbred virgin female (Ludwig/Wistar/Olac) rats bearing tumors induced with N-methyl-Nnitrosourea (NMU) |
Dosage form |
from 1.25 to 25 mg/kg ; subcutaneous injection; weekly for 4 wk. |
Application |
In all rats, all five gliotoxin-treated rats completing the study responded to treatment, three of which had >50% tumor regression (partial response) and two others with stable disease ( |
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1]. Vigushin DM, Mirsaidi N, Brooke G., et al. Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo. MEDICAL ONCOLOGY, 2004, 21(1):21-30. |
Gliotoxin is an immunosuppressive mycotoxin produced by pathogenic strains of Aspergillus and other fungi with diverse biological activities.[1],[2],[3],[4],[5],[6],[7],[8] It inhibits 20S proteasomal chymotrypsin activity (IC50 = 10 μM), blocking the degradation of IκBα and preventing the activation of NF-κB.[2],[3] Gliotoxin induces apoptosis in monocytes and dendritic cells and reduces phagocytosis by neutrophils.[4],[5]It suppresses viral infection by Nipah and Hendra virus in HEK293T cells (IC50s = 149 and 579 nM, respectively).[6] Under reducing conditions, gliotoxin inhibits leukotriene A4 hydrolase epoxide hydrolase activity, but not aminopeptidase activity, and leukotriene B4 synthesis in neutrophils and monocytes.[7] In vivo, gliotoxin (5 mg/kg) reduces LTB4 plasma levels and blocks peritoneal neutrophil infiltration in a mouse model of peritonitis induced by zymosan A. It also inhibits geranylgeranyltransferase I and farnesyltransferase (IC50s = 17 and 80 μM, respectively).[8]
Reference:
[1]. Kwon-Chung, K.J., and Sugui, J.A. What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus? Med. Mycol. 47(Suppl 1), S97-S103 (2009).
[2]. Kroll, M., Arenzana-Seisdedos, F., Bachelerie, F., et al. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem. Biol. 6(10), 689-698 (1999).
[3]. Pahl, H.L., Krauss, B., Schulze-Osthoff, K., et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med. 183(4), 1829-1840 (1996).
[4]. Anselmi, K., Stolz, D.B., Nalesnik, M., et al. Gliotoxin causes apoptosis and necrosis of rat Kupffer cells in vitro and in vivo in the absence of oxidative stress: Exacerbation by caspase and serine protease inhibition. J. Hepatol. 47(1), 103-113 (2007).
[5]. Orciuolo, E., Stanzani, M., Canestraro, M., et al. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: Implications for the pathogenesis of invasive aspergillosis. J. Leukoc. Biol. 82(4), 839-848 (2007).
[6]. Aljofan, M., Sganga, M.L., Lo, M.K., et al. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro. Virol. J. 6:187, (2009).
[7]. König, Pace, S., Pein, H., et al. Gliotoxin from Aspergillus fumigatus abrogates leukotriene B4 formation through inhibition of leukotriene A4 hydrolase. Cell. Chem. Biol. 26(4), 524-534 (2019).
[8]. Vigushin, D.M., Mirsaidi, N., Brooke, G., et al. Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo. Med. Oncol. 21(1), 21-30 (2004).
Cas No. | 67-99-2 | SDF | |
别名 | 胶霉毒素,Aspergillin | ||
化学名 | (3R,5aS,6S,10aR)-6-hydroxy-3-(hydroxymethyl)-2-methyl-2,3,5a,6-tetrahydro-1H-3,10a-epidithiopyrazino[1,2-a]indole-1,4(10H)-dione | ||
Canonical SMILES | O[C@H]1C=CC=C2[C@@H]1N(C([C@@]3(N4C)CO)=O)[C@@](C4=O)(SS3)C2 | ||
分子式 | C13H14N2O4S2 | 分子量 | 326.38 |
溶解度 | 5mg/mL in DMSO, or in DMF | 储存条件 | Store at -20°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.0639 mL | 15.3196 mL | 30.6391 mL |
5 mM | 0.6128 mL | 3.0639 mL | 6.1278 mL |
10 mM | 0.3064 mL | 1.532 mL | 3.0639 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。